Sign In
Buy VIVO
$3.90
+0.170 (+4.56%)
At Close: Aug 04, 2026
VivoPower appoints former Microsoft AI leader to advisory council
05:58am, Tuesday, 07'th Apr 2026
VivoPower PLC (NASDAQ:VIVO, FRA:51J) announced it has appointed artificial intelligence strategist Khadija Mustafa to its advisory council, as the company...
Ferrari upgraded to ‘Buy’ on growth confidence
09:17am, Tuesday, 31'st Mar 2026
Ferrari (NYSE:RACE) has been upgraded to a ‘Buy’ rating by Jefferies analysts, who cited renewed confidence in the luxury carmaker’s growth trajectory and...
Nvidia invests $2B in Marvell Technology as part of AI infrastructure partnership
07:13am, Tuesday, 31'st Mar 2026
Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) is investing $2 billion in Marvell Technology as part of a strategic partnership aimed at expanding its AI...
Meta shares tumble after legal setbacks, jury verdicts
09:55am, Thursday, 26'th Mar 2026
Shares of Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB) fell about 7.8% on Thursday afternoon, pressured by a series of legal setbacks, fresh layoffs...
VivoPower Receives Nasdaq Approval of Ticker “TEMB” for Planned Tembo Listing at a Targeted Valuation of $838 Million
09:10am, Thursday, 26'th Mar 2026
Ticker approval marks a key regulatory milestone for the listing of the business combination between VivoPower's subsidiary Tembo e-LV, and Cactus Acquisition Corporation I (CCTS)
Follows recently announced share acquisitions totaling 2.65 million shares by board members, including Executive Chairman and CEO, Kevin Chin, who purchased the majority of shares
VivoPower begins share conversion program to reduce public float, bolster long-term alignment
06:16am, Friday, 20'th Mar 2026
VivoPower PLC (NASDAQ:VIVO, FRA:51J) said on Friday it has begun converting a portion of its publicly traded shares into a restricted class held by...
VivoPower Terminates $180 Million F-3 Registration Statement
09:00am, Wednesday, 18'th Mar 2026
Decision reflects commitment to a strategy of non dilutive funding Alternative potential capital sources available at project level LONDON, March 18, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (Nasdaq: VI
VivoPower shares jump as it terminates $180M F-3 registration statement
06:17am, Wednesday, 18'th Mar 2026
Shares of VivoPower PLC (NASDAQ:VIVO, FRA:51J) surged 23.3% on Wednesday morning after the company announced it had terminated its $180 million Form F-3...
VivoPower Announces Effectiveness of New Stock Ticker “VIVO” and Corporate Name Change
07:05am, Monday, 16'th Mar 2026
LONDON, March 16, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner of powered land and data cen
VivoPower adopts new Nasdaq ticker ‘VIVO’ and completes name change
05:30am, Monday, 16'th Mar 2026
VivoPower PLC (NASDAQ:VIVO, FRA:51J) announced that its shares will begin trading under the new ticker ‘VIVO’ on the Nasdaq Composite starting March 16,...
VivoPower Announces New Stock Ticker “VIVO” and Corporate Name Change in Alignment with its Business Focus on AI Data Centers
09:20am, Tuesday, 10'th Mar 2026
LONDON, March 10, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner of powered land and data cen
Catheter Precision Received new VIVO Purchase Order from Leading Hospital in Slovenia
08:00am, Tuesday, 20'th Jan 2026
FORT MILL, S.C., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the ca
Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO
08:30am, Monday, 21'st Oct 2024
FORT MILL, SC / ACCESSWIRE / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac
Catheter Precision Continues to Expand Clinical Data and Acceptance of VIVO
08:30am, Wednesday, 02'nd Oct 2024
FORT MILL, SC / ACCESSWIRE / October 2, 2024 / Catheter Precision, Inc. (NYSE/American:VTAK), a company dedicated in the development and marketing of technologically advanced products for the cardiac
